Pharmaceutical Technologies

The following section deals with manufacturing technologies of Pharmaceuticals and up-to-date pharmaceutical equipment

Monopoly Signs on Pharma Equipment Market Eliminated in Russia

The Federal Service for Healthcare Supervision executed FAS warning to stop actions (omissions) that contained signs of violating the antimonopoly law. As informed earlier, re-registering pharmaceu...

GeoVax and Leidos to Develop Malaria Vaccine Candidates

GeoVax Labs, Inc., a biotechnology company developing human vaccines, announced today that it has expanded its collaboration activities with Leidos, Inc. to develop malaria vaccine candidates. The wor...

PPD and HLT of China in Exclusive Agreement

Pharmaceutical Product Development, LLC (PPD) and Happy Life Tech (HLT) of China have signed an exclusive agreement to develop a distinctive service offering for the China drug-development market deli...

Anixa, Wistar Institute and Dmitry I. Gabrilovich Focus on MDSC

Anixa Biosciences, Inc., a biotechnology company focused on using the body's immune system to fight cancer, today announced it has extended its collaboration with The Wistar Institute and Dmitry I. Ga...
amgen

Abilita Bio and Amgen in Multi-Target Research Team

Abilita Bio, Inc. announced that it has entered into a multi-target research collaboration agreement with Amgen, a world leader in biotechnology. Under the terms of the agreement, Abilita Bio will lev...

WuXi and Amicus are into Exclusive Manufacturing Partnership

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Amicus Therapeutics, a glob...

Grey Wolf to Fund Development of Therapy Increasing Tumour Visibility

Grey Wolf targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system. Grey Wolf Therapeutics, a drug discovery ...

Launch of Company Focusing on Preventing Cancer Metastasis

HiberCell, a biotechnology company developing therapeutics focused on preventing cancer relapse and metastasis, launched on February 8 with $60.75M in Series A funding led by ARCH Venture Partners. Hi...

Video

Expert opinion